{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:14:40Z","timestamp":1788250480171,"version":"build-2803163510"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["T35AG044303"],"award-info":[{"award-number":["T35AG044303"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s11060-026-05721-1","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T09:11:22Z","timestamp":1784625082000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Frameless stereotactic radiosurgery in the management of brain metastases: long-term oncologic and toxicity outcomes"],"prefix":"10.1007","volume":"179","author":[{"given":"Swati","family":"Kinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Sedor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth J.","family":"Buss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Giannaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Testaiuti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian J. A.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brett E.","family":"Youngerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Raymond F.","family":"Sekula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy M.","family":"McKhann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B.","family":"Sisti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Bruce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon K.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony J. C.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Gallitto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"issue":"11","key":"5721_CR1","first-page":"4655","volume":"32","author":"E Tabouret","year":"2012","unstructured":"Tabouret E, Chinot O, Metellus P, Tallet A, Viens P, Gon\u00e7alves A (2012) Recent trends in epidemiology of brain metastases: an overview. Anticancer Res 32(11):4655\u20134662","journal-title":"Anticancer Res"},{"issue":"2","key":"5721_CR2","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1007\/BF01053937","volume":"15","author":"W Boogerd","year":"1993","unstructured":"Boogerd W, Vos VW, Hart AA, Baris G (1993) Brain metastases in breast cancer; natural history, prognostic factors and outcome. J Neurooncol 15(2):165\u2013174. https:\/\/doi.org\/10.1007\/BF01053937","journal-title":"J Neurooncol"},{"issue":"5","key":"5721_CR3","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1227\/neu.0000000000002542","volume":"93","author":"Z Schnurman","year":"2023","unstructured":"Schnurman Z, Mashiach E, Link KE et al (2023) Causes of death in patients with brain metastases. Neurosurgery 93(5):986\u2013993. https:\/\/doi.org\/10.1227\/neu.0000000000002542","journal-title":"Neurosurgery"},{"issue":"1","key":"5721_CR4","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s13014-022-02062-x","volume":"17","author":"C Nieder","year":"2022","unstructured":"Nieder C, Stanisavljevic L, Aanes SG, Manns\u00e5ker B, Haukland EC (2022) 30-day mortality in patients treated for brain metastases: extracranial causes dominate. Radiat Oncol 17(1):92. https:\/\/doi.org\/10.1186\/s13014-022-02062-x","journal-title":"Radiat Oncol"},{"issue":"11","key":"5721_CR5","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1016\/S1470-2045(09)70263-3","volume":"10","author":"EL Chang","year":"2009","unstructured":"Chang EL, Wefel JS, Hess KR et al (2009) Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial. Lancet Oncol 10(11):1037\u20131044. https:\/\/doi.org\/10.1016\/S1470-2045(09)70263-3","journal-title":"Lancet Oncol"},{"issue":"2","key":"5721_CR6","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1200\/JCO.2010.30.1655","volume":"29","author":"M Kocher","year":"2011","unstructured":"Kocher M, Soffietti R, Abacioglu U et al (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952\u201326001 study. J Clin Oncol 29(2):134\u2013141. https:\/\/doi.org\/10.1200\/JCO.2010.30.1655","journal-title":"J Clin Oncol"},{"issue":"5","key":"5721_CR7","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1200\/JCO.21.02314","volume":"40","author":"MA Vogelbaum","year":"2022","unstructured":"Vogelbaum MA, Brown PD, Messersmith H et al (2022) Treatment for brain metastases: ASCO-SNO-ASTRO guideline. J Clin Oncol 40(5):492\u2013516. https:\/\/doi.org\/10.1200\/JCO.21.02314","journal-title":"J Clin Oncol"},{"issue":"8","key":"5721_CR8","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S1470-2045(17)30441-2","volume":"18","author":"PD Brown","year":"2017","unstructured":"Brown PD, Ballman KV, Cerhan JH et al (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C\/CEC\u00b73): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8):1049\u20131060. https:\/\/doi.org\/10.1016\/S1470-2045(17)30441-2","journal-title":"Lancet Oncol"},{"issue":"8","key":"5721_CR9","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/S1470-2045(17)30414-X","volume":"18","author":"A Mahajan","year":"2017","unstructured":"Mahajan A, Ahmed S, McAleer MF et al (2017) Post-operative stereotactic radiosurgery versus observation for completely resected brain metastases: a single-centre, randomised, controlled, phase 3 trial. Lancet Oncol 18(8):1040\u20131048. https:\/\/doi.org\/10.1016\/S1470-2045(17)30414-X","journal-title":"Lancet Oncol"},{"issue":"33","key":"5721_CR10","doi-asserted-by":"publisher","first-page":"3282","DOI":"10.1200\/JCO.2018.78.6186","volume":"36","author":"T Kayama","year":"2018","unstructured":"Kayama T, Sato S, Sakurada K et al (2018) Effects of surgery with salvage stereotactic radiosurgery versus surgery with whole-brain radiation therapy in patients with one to four brain metastases (JCOG0504): A phase III, noninferiority, randomized controlled trial. J Clin Oncol 36(33):3282\u20133289. https:\/\/doi.org\/10.1200\/JCO.2018.78.6186","journal-title":"J Clin Oncol"},{"issue":"16suppl","key":"5721_CR11","doi-asserted-by":"publisher","first-page":"2011","DOI":"10.1200\/JCO.2025.43.16_suppl.2011","volume":"43","author":"A Aizer","year":"2025","unstructured":"Aizer A, Tanguturi SK, Benham G et al (2025) Stereotactic radiation versus hippocampal avoidance whole brain radiation in patients with 5\u201320 brain metastases: A multicenter, phase 3 randomized trial. J Clin Oncol 43(16suppl):2011. https:\/\/doi.org\/10.1200\/JCO.2025.43.16_suppl.2011","journal-title":"J Clin Oncol"},{"issue":"4","key":"5721_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/neuros\/nyz227","volume":"86","author":"H Vulpe","year":"2020","unstructured":"Vulpe H, Save AV, Xu Y et al (2020) Frameless stereotactic radiosurgery on the Gamma Knife Icon: Early experience from 100 patients. Neurosurgery 86(4):509\u2013516. https:\/\/doi.org\/10.1093\/neuros\/nyz227","journal-title":"Neurosurgery"},{"issue":"3","key":"5721_CR13","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s11060-009-9830-7","volume":"92","author":"W Clifford","year":"2009","unstructured":"Clifford W, Sharpe H, Khu KJ, Cusimano M, Knifed E, Bernstein M (2009) Gamma Knife patients\u2019 experience: lessons learned from a qualitative study. J Neurooncol 92(3):387\u2013392. https:\/\/doi.org\/10.1007\/s11060-009-9830-7","journal-title":"J Neurooncol"},{"issue":"3","key":"5721_CR14","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000511587","volume":"99","author":"M Pavlica","year":"2021","unstructured":"Pavlica M, Dawley T, Goenka A, Schulder M (2021) Frame-based and mask-based stereotactic radiosurgery: the patient experience, compared. Stereotact Funct Neurosurg 99(3):241\u2013249. https:\/\/doi.org\/10.1159\/000511587","journal-title":"Stereotact Funct Neurosurg"},{"issue":"4","key":"5721_CR15","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.jmir.2020.08.001","volume":"51","author":"W Li","year":"2020","unstructured":"Li W, Cashell A, Lee I et al (2020) Patient perspectives on frame versus mask immobilization for Gamma Knife stereotactic radiosurgery. J Med Imaging Radiat Sci 51(4):567\u2013573. https:\/\/doi.org\/10.1016\/j.jmir.2020.08.001","journal-title":"J Med Imaging Radiat Sci"},{"issue":"Suppl1","key":"5721_CR16","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3171\/2018.7.GKS181516","volume":"129","author":"A Carminucci","year":"2018","unstructured":"Carminucci A, Nie K, Weiner J, Hargreaves E, Danish SF (2018) Assessment of motion error for frame-based and noninvasive mask-based fixation using the Leksell Gamma Knife Icon radiosurgery system. J Neurosurg 129(Suppl1):133\u2013139. https:\/\/doi.org\/10.3171\/2018.7.GKS181516","journal-title":"J Neurosurg"},{"issue":"5","key":"5721_CR17","doi-asserted-by":"publisher","first-page":"100736","DOI":"10.1016\/j.adro.2021.100736","volume":"6","author":"RE Wegner","year":"2021","unstructured":"Wegner RE, Horne ZD, Liang Y et al (2021) Single fraction frameless stereotactic radiosurgery on the Gamma Knife Icon for patients with brain metastases: time to abandon the frame? Adv Radiat Oncol 6(5):100736. https:\/\/doi.org\/10.1016\/j.adro.2021.100736","journal-title":"Adv Radiat Oncol"},{"issue":"14","key":"5721_CR18","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.3390\/cancers14143392","volume":"14","author":"T Kutuk","year":"2022","unstructured":"Kutuk T, Kotecha R, Tolakanahalli R et al (2022) Zero setup margin mask versus frame immobilization during Gamma Knife\u00ae Icon\u2122 stereotactic radiosurgery for brain metastases. Cancers (Basel) 14(14):3392. https:\/\/doi.org\/10.3390\/cancers14143392","journal-title":"Cancers (Basel)"},{"issue":"2","key":"5721_CR19","doi-asserted-by":"publisher","first-page":"E29","DOI":"10.1016\/j.ijrobp.2020.02.531","volume":"108","author":"E Buss","year":"2020","unstructured":"Buss E, Vulpe H, Jacobson J et al (2020) Single-fraction stereotactic radiosurgery outcomes for brain metastases with frameless Gamma Knife ICON radiosurgery. Int J Radiat Oncol Biol Phys 108(2):E29. https:\/\/doi.org\/10.1016\/j.ijrobp.2020.02.531","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"5721_CR20","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1186\/s12885-022-10162-w","volume":"22","author":"M Gallitto","year":"2022","unstructured":"Gallitto M, Savacool M, Lee A, Wang TJC, Sisti MB (2022) Feasibility of fractionated gamma knife radiosurgery in the management of newly diagnosed Glioblastoma. BMC Cancer 22(1):1095. https:\/\/doi.org\/10.1186\/s12885-022-10162-w","journal-title":"BMC Cancer"},{"issue":"6","key":"5721_CR21","doi-asserted-by":"publisher","first-page":"e270","DOI":"10.1016\/S1470-2045(15)70057-4","volume":"16","author":"NU Lin","year":"2015","unstructured":"Lin NU, Lee EQ, Aoyama H et al (2015) Response assessment criteria for brain metastases: proposal from the RANO group. Lancet Oncol 16(6):e270\u2013e278. https:\/\/doi.org\/10.1016\/S1470-2045(15)70057-4","journal-title":"Lancet Oncol"},{"issue":"282","key":"5721_CR22","doi-asserted-by":"publisher","first-page":"457","DOI":"10.2307\/2281868","volume":"53","author":"EL Kaplan","year":"1958","unstructured":"Kaplan EL, Meier P (1958) Nonparametric estimation from incomplete observations. JASA 53(282):457\u2013481. https:\/\/doi.org\/10.2307\/2281868","journal-title":"JASA"},{"issue":"2","key":"5721_CR23","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","volume":"34","author":"DR Cox","year":"1972","unstructured":"Cox DR (1972) Regression models and life-tables. J R 34(2):187\u2013220. https:\/\/doi.org\/10.1111\/j.2517-6161.1972.tb00899.x. Stat Soc B.","journal-title":"J R"},{"key":"5721_CR24","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.radonc.2020.05.011","volume":"147","author":"MA Grimm","year":"2020","unstructured":"Grimm MA, K\u00f6ppen U, Stieler F et al (2020) Prospective assessment of mask versus frame fixation during Gamma Knife treatment for brain metastases. Radiother Oncol 147:195\u2013199. https:\/\/doi.org\/10.1016\/j.radonc.2020.05.011","journal-title":"Radiother Oncol"},{"issue":"2","key":"5721_CR25","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1159\/000519280","volume":"100","author":"J R\u00e9gis","year":"2022","unstructured":"R\u00e9gis J, Merly L, Balossier A et al (2022) Mask-based versus frame-based Gamma Knife ICON radiosurgery in brain metastases: a prospective randomized trial. Stereotact Funct Neurosurg 100(2):86\u201394. https:\/\/doi.org\/10.1159\/000519280","journal-title":"Stereotact Funct Neurosurg"},{"issue":"1","key":"5721_CR26","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s11060-024-04738-8","volume":"170","author":"PS Pichardo-Rojas","year":"2024","unstructured":"Pichardo-Rojas PS, V\u00e1zquez-Alva D, Alvarez-Castro JA et al (2024) Comparative effectiveness of frame-based and mask-based Gamma Knife stereotactic radiosurgery in brain metastases: A 509 patient meta-analysis. J Neurooncol 170(1):53\u201366. https:\/\/doi.org\/10.1007\/s11060-024-04738-8","journal-title":"J Neurooncol"},{"key":"5721_CR27","doi-asserted-by":"publisher","first-page":"111195","DOI":"10.1016\/j.jocn.2025.111195","volume":"135","author":"W Hoyt","year":"2025","unstructured":"Hoyt W, Oslin S, Algan O et al (2025) Mask-based vs. frame-based stereotactic radiosurgery: A systematic review. J Clin Neurosci 135:111195. https:\/\/doi.org\/10.1016\/j.jocn.2025.111195","journal-title":"J Clin Neurosci"},{"issue":"30","key":"5721_CR28","doi-asserted-by":"publisher","first-page":"3606","DOI":"10.1200\/JCO.23.02668","volume":"42","author":"LRG Pike","year":"2024","unstructured":"Pike LRG, Miao E, Boe LA et al (2024) Tyrosine kinase inhibitors with and without up-front stereotactic radiosurgery for brain metastases from EGFR and ALK oncogene-driven non-small cell lung cancer (TURBO-NSCLC). J Clin Oncol 42(30):3606\u20133617. https:\/\/doi.org\/10.1200\/JCO.23.02668","journal-title":"J Clin Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05721-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11060-026-05721-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11060-026-05721-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T07:27:08Z","timestamp":1788247628000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11060-026-05721-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5721"],"URL":"https:\/\/doi.org\/10.1007\/s11060-026-05721-1","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"value":"0167-594X","type":"print"},{"value":"1573-7373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]},"assertion":[{"value":"26 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the institutional review board (IRB) of Columbia University, which functions as the institutional research ethics committee.","order":1,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients provided informed consent for inclusion in the institutional database, which served as the source of data for this study.","order":2,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"T.J.C.W. reports receiving grants and non-financial support from Genentech and Varian, receiving personal fees from Wolters Kluwer, AbbVie, Cancer Panels, Elekta, Merck, RTOG Foundation, and Iylon Precision, participating in Data Safety Monitoring\/Advisory Boards at Iylon Precision and Columbia University Herbert Irving Comprehensive Cancer Center, and owning stock in Doximity. All other authors have no disclosures.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"4"}}